Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ACAD Historical Stock Prices |
| Preferred Stock Newsletter |
| ACAD Options Chain |
| Stock Message Boards |
Acadia Pharmaceuticals (ACAD) has the following price history information. Looking back at ACAD historical stock prices for the last five trading days, on January 23, 2023, ACAD opened at $19.38, traded as high as $19.74 and as low as $18.96, and closed at $19.09. Trading volume was a total of 2.51M shares. On January 24, 2023, ACAD opened at $19.01, traded as high as $19.54 and as low as $18.88, and closed at $19.00. Trading volume was a total of 915.20K shares. On January 25, 2023, ACAD opened at $18.85, traded as high as $19.18 and as low as $18.40, and closed at $18.69. Trading volume was a total of 943.90K shares. On January 26, 2023, ACAD opened at $18.79, traded as high as $18.96 and as low as $18.40, and closed at $18.66. Trading volume was a total of 1.38M shares. On January 27, 2023, ACAD opened at $18.57, traded as high as $18.77 and as low as $18.39, and closed at $18.57. Trading volume was a total of 935.20K shares.
ACAD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acadia Pharmaceuticals shares, starting with a $10,000 purchase of ACAD, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 01/30/2013 | |
| End date: | 01/27/2023 | |
| Start price/share: | $6.15 | |
| End price/share: | $18.57 | |
| Dividends collected/share: | $0.00 | |
| Total return: | 201.95% | |
| Average Annual Total Return: | 11.69% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $30,200.31 | |
| Years: | 10.00 | |
 | |||||
| ACAD Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 01/23/2023 | $19.38 | $19.74 | $18.96 | $19.09 | 2.51M |
| 01/24/2023 | $19.01 | $19.54 | $18.88 | $19.00 | 915.20K |
| 01/25/2023 | $18.85 | $19.18 | $18.40 | $18.69 | 943.90K |
| 01/26/2023 | $18.79 | $18.96 | $18.40 | $18.66 | 1.38M |
| 01/27/2023 | $18.57 | $18.77 | $18.39 | $18.57 | 935.20K |
|
| About Acadia Pharmaceuticals |
| Acadia Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system disorders. Co. has a portfolio of product including its drug, NUPLAZID (pimavanserin), which has been approved by the U.S. Food and Drug Administration for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. NUPLAZID is a selective serotonin inverse agonist/antagonist, targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors. |
| ACAD Historical Closing Prices | |
| Date | Close |
| 01/23/2023 | $19.09 |
| 01/24/2023 | $19.00 |
| 01/25/2023 | $18.69 |
| 01/26/2023 | $18.66 |
| 01/27/2023 | $18.57 |
| Healthcare Historical Prices |
| ACAD is categorized under the Healthcare sector; below are some other companies in the same sector:
ACER Historical Stock Prices Also explore: ACAD shares outstanding history
|
Free ACAD Email Alerts:
